Clinician's Roundtable

Dr. David Weisman explores a study from Wake Forest School of Medicine that examined the effects of concussions for youth football participants.

What does it take to pick up your practice and move to a foreign country? And what can be gained and lost in translation?

Host Dr. Renee Allen chats with Dr. Carmen Brown,a board-certified OB/GYN practicing in New Zealand, about her experiences and perspectives transitioning a clinical practice and family home to another continent.

Rheumatic diseases don't discriminate across race or gender; however, significant health disparities continue to exist for patients suffering from these diseases.

Dr. Renée Simone Yolanda Allen speaks with Dr. Xena Whittier, practicing rheumatologist with WellStar Rheumatology Associates in Marietta, GA, about closing the gap in health disparities for rheumatology patients across genders, ethnicities, and socioeconomic statuses.

The OB/GYN hospitalist model is one potential approach to enhancing the quality and safety of hospital’s obstetric–gynecologic services and reducing the incidence of adverse events

Host Dr. Renee Allen sits down with Dr. Rob Olson, an OB/GYN hospitalist program consultant with over 7 years experience practicing in this role. Dr. Olson is founding President of the newly formed Society of OB/GYN Hospitalists, and he speaks nationally on the many benefits of OB/GYN Hospitalist models of care.

From the Women's Health Annual Visit in Chicago, host Ana Maria Rosario talks with Dr. Martin Chavez, the Director of Maternal Fetal Medicine and Fetal Surgery Program at Winthrop University Hospital, about the maternal-fetal effects of the Zika virus outbreak.

Reports indicate that there is a national upsurge in the number of women with opioid addiction. The problem is multigenerational, with consumption habits that begin as early as the mid-teenage years and extend well into the elderly population.

Additionally, opioid addiction disproportionately affects women, who are more likely to become dependent and overdose unintentionally on painkillers compared to men.

Host Dr. Patrice Basanta-Henry talks with Dr. Regan Theiler, Director of the Division of General OB/GYN at Dartmouth-Hitchcock Medical Center about treatment approaches for opioid-addicted pregnant women and women of childbearing age.

Prescription drugs are often essential to the management of both acute and chronic pain. However, misuse, abuse and additions to these products, especially opioids, have become a worldwide epidemic. Since 1999, the number of overdose deaths involving opioids have almost quadrupled in the United States.

Host Dr. Patrice Basanta-Henry talks with psychiatrist and addiction medicine specialist Dr. Nzinga Harrison, CMO of Anka Behavioral Health Inc., about the physician's role in the face of this opioid epidemic.

Many menopausal and perimenopausal women are faced with the decision of whether synthetic or bioidentical hormone therapy is the best option for them. There are many pros and cons for each, but questions surface from patients and clinicians alike on comparative safety and efficacy profiles.

Host Dr. Renee Allen welcomes Dr. Jocelyn Slaughter-Moore, a board-certified practicing OB/GYN at Heras Healthcare for Women. They talk about the differences between bioidentical and synthetic hormones, and whether bioidentical hormone therapy is a safe option for women.

Advances in technology have resulted in increased information being available for pregnant woman. With this increased information has come a rise in the number of requests for termination of pregnancy for fetal indications. However, termination of pregnancy remains a controversial issue in the area of women’s health. Women requesting second trimester terminations may face significant legal barriers as well as poor access to providers and/or facilities that are able to provide the procedure.

Host Dr. Patrice Basanta-Henry chats with Dr. Reagan Theiler, Division Director for General Obstetrics and Gynecology and Director of Ryan Residency Training Program at the Dartmouth Hitchcock Center and the controversy surrounding second trimester termination.

According to the American Congress of Obstetricians and Gynecologists, between 14% and 23% of women will struggle with some symptoms of depression during their pregnancy. This condition often goes unrecognized and untreated in part because of safety concerns in using medications or other therapeutic methods during pregnancy.

Host Dr. Patrice Basanta-Henry talks with Dr. Nzinga Harrison, a board-certified physician in addiction medicine and psychiatry and Chief Medical Officer for Anka Behavioral Health, Inc about the current recommendations for depression screenings in the pregnant patient.